BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 28558091)

  • 21. Use of long-acting reversible contraceptives to reduce the rate of teen pregnancy.
    Rome E
    Cleve Clin J Med; 2015 Nov; 82(11 Suppl 1):S8-12. PubMed ID: 26555813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long acting reversible contraception in postpartum adolescents: early initiation of etonogestrel implant is superior to IUDs in the outpatient setting.
    Tocce K; Sheeder J; Python J; Teal SB
    J Pediatr Adolesc Gynecol; 2012 Feb; 25(1):59-63. PubMed ID: 22051792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-acting reversible contraception for adolescents.
    McNicholas C; Peipert JF
    Curr Opin Obstet Gynecol; 2012 Oct; 24(5):293-8. PubMed ID: 22781078
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-acting reversible contraception.
    Peck SA
    Nurs Womens Health; 2013 Oct; 17(5):431-5. PubMed ID: 24138662
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adolescent Long-Acting Reversible Contraceptive Use, Same-Day Insertions, and Pregnancies Following a Quality Initiative.
    Bruce KH; Merchant MA; Kaskowitz AP; Mickelsen RS; Lau JS
    J Adolesc Health; 2023 Nov; 73(5):946-952. PubMed ID: 37436353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New york city physicians' views of providing long-acting reversible contraception to adolescents.
    Rubin SE; Davis K; McKee MD
    Ann Fam Med; 2013; 11(2):130-6. PubMed ID: 23508599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Eliminating health disparities in unintended pregnancy with long-acting reversible contraception (LARC).
    Parks C; Peipert JF
    Am J Obstet Gynecol; 2016 Jun; 214(6):681-8. PubMed ID: 26875950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors Associated with New Uptake of Long-Acting Reversible Contraceptives Since the Affordable Care Act Among Privately Insured Women in Pennsylvania.
    Nelson HN; Thayer E; Bailey C; Leuenberger L; Lehman E; Chuang CH
    Womens Health Issues; 2019; 29(5):370-375. PubMed ID: 31337530
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retrospective analysis of the impact of increasing access to long acting reversible contraceptives in a commercially insured population.
    Law A; Pilon D; Lynen R; Laliberté F; Gozalo L; Lefebvre P; Duh MS
    Reprod Health; 2016 Aug; 13(1):96. PubMed ID: 27549429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-Acting Reversible Contraception: An Essential Guide for Pediatric Primary Care Providers.
    Allen S; Barlow E
    Pediatr Clin North Am; 2017 Apr; 64(2):359-369. PubMed ID: 28292451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Understanding the low uptake of long-acting reversible contraception by young women in Australia: a qualitative study.
    Garrett CC; Keogh LA; Kavanagh A; Tomnay J; Hocking JS
    BMC Womens Health; 2015 Sep; 15():72. PubMed ID: 26359250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dual use of long-acting reversible contraceptives and condoms among adolescents.
    Williams RL; Fortenberry JD
    J Adolesc Health; 2013 Apr; 52(4 Suppl):S29-34. PubMed ID: 23535054
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intrauterine Contraception Continuation in Adolescents and Young Women: A Systematic Review.
    Usinger KM; Gola SB; Weis M; Smaldone A
    J Pediatr Adolesc Gynecol; 2016 Dec; 29(6):659-667. PubMed ID: 27386754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors associated with short interpregnancy interval in women who plan postpartum LARC: a retrospective study.
    Harney C; Dude A; Haider S
    Contraception; 2017 Mar; 95(3):245-250. PubMed ID: 27589883
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current challenges in contraception in adolescents and young women.
    Cornet A
    Curr Opin Obstet Gynecol; 2013 Mar; 25 Suppl 1():S1-10. PubMed ID: 23370330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Not seeking yet trying long-acting reversible contraception: a 24-month randomized trial on continuation, unintended pregnancy and satisfaction.
    Hubacher D; Spector H; Monteith C; Chen PL
    Contraception; 2018 Jun; 97(6):524-532. PubMed ID: 29470950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-Acting Reversible Contraception: A Primer for the Primary Care Pediatrician.
    Fernandez S
    Pediatr Ann; 2017 Mar; 46(3):e79-e82. PubMed ID: 28287679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Let's talk about sex (again): advancing the conversation around long-acting reversible contraception for teenagers.
    Satterwhite CL; Ramaswamy M
    Womens Health (Lond); 2015 Nov; 11(6):841-50. PubMed ID: 26626398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost Savings and Effectiveness of Long-Acting Reversible Contraception (LARC) on the Prevention of Pregnancy in Adolescents: A Systematic Review.
    Marmett B; Guaranha DDFK; Carvalho AF; Reis JM; Souza CLE; Dalcin TC; Amantéa SL
    J Pediatr Adolesc Gynecol; 2024 Feb; 37(1):11-17. PubMed ID: 37802383
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Familiarity with Long-acting Reversible Contraceptives among Obstetrics and Gynecology, Family Medicine, and Pediatrics Residents: Results of a 2015 National Survey and Implications for Contraceptive Provision for Adolescents.
    Davis SA; Braykov NP; Lathrop E; Haddad LB
    J Pediatr Adolesc Gynecol; 2018 Feb; 31(1):40-44. PubMed ID: 28942106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.